Related Experiment Video
Updated: May 2, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Epidemiology and risk factors for invasive candidiasis
1Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Dokuz Eylül University, İzmir, Turkey.
Abstract:
The number of immunosuppressive patients has increased significantly in recent years. These patients are at risk for opportunistic infections, especially fungal infections. Candidiasis is one of the most frequent fungal infections determined in these immunosuppressive patients and its epidemiology has changed over the last two decades. Recently, new antifungal agents and new therapy strategies such as antifungal prophylaxis, secondary prophylaxis, and preemptive therapy have come into use. These changes resulted in the alteration of Candida species causing invasive infections. The incidence of Candida albicans was decreased in many countries, especially among patients with immunosuppressive disorders, while the incidence of species other than C. albicans was increased. In this review, incidence, risk factors, and species distribution of invasive candidiasis are discussed.
Insights
The incidence of invasive candidiasis has shifted, with Candida albicans decreasing and non-albicans Candida species increasing, particularly in immunosuppressive patients. This review examines the changing epidemiology, risk factors, and species distribution of these fungal infections.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Epidemiology
Background:
- Immunosuppressive patient populations are growing, increasing susceptibility to opportunistic infections.
- Candidiasis remains a frequent fungal infection in these at-risk individuals.
- Recent advancements in antifungal therapies and treatment strategies have influenced infection patterns.
Purpose of the Study:
- To review the current epidemiology of invasive candidiasis.
- To identify key risk factors associated with invasive candidiasis.
- To analyze the changing species distribution of Candida in invasive infections.
Main Methods:
- Literature review focusing on invasive candidiasis.
- Analysis of epidemiological data and trends over the past two decades.
- Examination of studies on antifungal prophylaxis, secondary prophylaxis, and preemptive therapy.
Main Results:
- A significant increase in non-albicans Candida species causing invasive infections.
- A notable decrease in the incidence of Candida albicans, especially in immunosuppressed patients.
- Changes in Candida species distribution are linked to new therapeutic strategies.
Conclusions:
- The epidemiology of invasive candidiasis is evolving, with a rise in non-albicans Candida.
- Understanding these shifts is crucial for effective antifungal treatment and prevention strategies.
- Continued surveillance of Candida species distribution is necessary for public health.
More Related Videos
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Endocarditis I: Introduction
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Fungal Phylum Microsporidia
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...

